Midazolam
Back to searchMolecule Structure
Scientific Name
Midazolam
Description of the Drug
Midazolam is a short-acting benzodiazepine with rapid onset that is commonly used in seizures, anesthesia and anxiety disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00683
http://www.drugbank.ca/drugs/DB00683
Brand Name(s)
Midazolam in 0.8% sodium chloride, Midazolam in 0.9% sodium chloride, Nayzilam
Company Owner(s)
Inforlife Sa, Igi Laboratories Inc, Atlantide Pharmaceuticals Ag, Akorn Operating Co Llc, Hikma Pharmaceuticals International Ltd, Bedford Laboratories Div Ben Venue Laboratories Inc, Meridian Medical Technologies Llc, Fresenius Kabi Usa Llc, Steriscience Pte Ltd, Apothecon Inc Div Bristol Myers Squibb
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35061 | ||||
PharmGKB | PA450496 | ||||
Human Metabolome Database | HMDB0014821 | ||||
DrugBank | DB00683 | ||||
PubChem: Thomson Pharma | 14850779 | ||||
PubChem | 4192 | ||||
LINCS | LSM-5200 | ||||
Nikkaji | J31.859K | ||||
PDBe | 08J | ||||
BindingDB | 21363 | ||||
EPA CompTox Dashboard | DTXSID5023320 | ||||
DrugCentral | 1802 | ||||
Brenda | 145058 | 12205 | 145972 | ||
ChemicalBook | CB0418580 | ||||
Guide to Pharmacology | 3342 | ||||
rxnorm | MIDAZOLAM MALEATE | MIDAZOLAM | SEIZALAM | MIDAZOLAM HYDROCHLORIDE | NAYZILAM |
KEGG Ligand | C07524 | ||||
ChEBI | 6931 | ||||
ZINC | ZINC000095626706 |